Nomura Holdings Inc. Takes Position in Olink Holding AB (publ) (NASDAQ:OLK)

Nomura Holdings Inc. purchased a new position in shares of Olink Holding AB (publ) (NASDAQ:OLK) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 123,840 shares of the company’s stock, valued at approximately $3,115,000. Nomura Holdings Inc. owned approximately 0.10% of Olink Holding AB (publ) as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Picton Mahoney Asset Management bought a new stake in shares of Olink Holding AB (publ) during the fourth quarter valued at approximately $1,300,000. New York Life Investment Management LLC bought a new position in Olink Holding AB (publ) in the 4th quarter valued at $6,522,000. Virtu Financial LLC bought a new position in Olink Holding AB (publ) in the 4th quarter valued at $1,061,000. Water Island Capital LLC bought a new stake in shares of Olink Holding AB (publ) during the fourth quarter worth $41,360,000. Finally, Flow State Investments L.P. acquired a new position in shares of Olink Holding AB (publ) during the fourth quarter valued at $1,509,000. Institutional investors own 30.19% of the company’s stock.

Olink Holding AB (publ) Stock Down 0.2 %

Shares of OLK stock opened at $25.50 on Wednesday. The stock has a 50-day moving average of $23.63 and a 200-day moving average of $24.15. Olink Holding AB has a one year low of $14.10 and a one year high of $26.01.

Olink Holding AB (publ) (NASDAQ:OLK) last announced its quarterly earnings results on Monday, May 13th. The company reported ($0.13) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.01). Olink Holding AB (publ) had a negative return on equity of 7.07% and a negative net margin of 19.72%. The firm had revenue of $28.75 million for the quarter, compared to the consensus estimate of $31.29 million. As a group, research analysts expect that Olink Holding AB will post -0.19 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on OLK. Canaccord Genuity Group reissued a “hold” rating and set a $26.00 price objective on shares of Olink Holding AB (publ) in a report on Tuesday, March 26th. Morgan Stanley reaffirmed an “equal weight” rating and issued a $26.00 price objective on shares of Olink Holding AB (publ) in a research note on Tuesday, March 26th.

Olink Holding AB (publ) Profile

Olink Holding AB (publ) develops, produces, markets, and sells biotechnological products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore that consist of Explore 372 and Explore 384 for cardiovascular and metabolic, oncology, neurology, and inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on.